Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 3 days ago Contract notice

Poland - Pharmaceutical products - Purchase and delivery of cytostatic drugs for the Hospital Pharmacy of the Holy Cross Cancer Centre in Kielce

Original Polska - Produkty farmaceutyczne - Zakup i dostawa leków cytostatycznych dla Apteki Szpitalnej Świętokrzyskiego Centrum Onkologii w Kielcach

Open Poland Świętokrzyskie Medical equipment & pharmaceuticals

Buyer Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach

13 days left

Key facts

Closes
10:00 (UTC+1)
Competition
Open race
  1. Published
  2. Today
  3. Deadline open for 29 days
  4. Awarded pending

Bidding window

29 days from publication to deadline

Usual length

Notices of this kind (Poland, open procedure, above the EU threshold) give a median of 28 days, half of them between 13 and 33 days, based on 83,050 notices of the last two years.

This buyer usually gives 30 days (median of its last 141 calls for tender).

View the official notice Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

The Aperlena Verdict

Open race

No supplier dominates: 52 different companies have won the last 53 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Based on 53 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The Holy Cross Cancer Centre in Kielce is procuring the purchase and delivery of cytostatic drugs for its hospital pharmacy. The procurement is divided into 16 lots, each dedicated to one active substance: Lot 1 Crizotinib, Lot 2 Afatinib, Lot 3 Azacitidine, Lot 4 Zanubrutinib, Lot 5 Lorlatinib, Lot 6 Regorafenib, Lot 7 Ripretinib, Lot 8 Blinatumomab, Lot 9 Adagrasib, Lot 10 Ivosidenib, Lot 11 Ponatinib, Lot 12 Bosutinib, Lot 13 Acidum zoledronicum, Lot 14 Gemtuzumab, Lot 15 Midostaurin and Lot 16 Immunoglobulin. Detailed assortment requirements for each lot are set out in the assortment and price forms attached as Annex 1a to the terms of reference.

Description

Przedmiotem zamówienia jest zakup i dostawa leków cytostatycznych dla Apteki Szpitalnej Świętokrzyskiego Centrum Onkologii w Kielcach. Przedmiot zamówienia jest podzielony na następujące części: Pakiet 1 - Crizotinib Pakiet 2 - Afatinib Pakiet 3 - Azacitidine Pakiet 4 - Zanubrutynib Pakiet 5 - Lorlatinib Pakiet 6 - Regorafenib Pakiet 7 - Ripretinib Pakiet 8 - Blinatumomab Pakiet 9 - Adagrasib Pakiet 10 - Ivosidenib Pakiet 11 - Ponatinib Pakiet 12 - Bosutinib Pakiet 13 - Acidum zoledronicum Pakiet 14 - Gemtuzumab Pakiet 15 - Midostaurin Pakiet 16 - Immunoglobulina. Szczegółowe wymagania dotyczące asortymentu znajdują się pod każdym z Formularzy asortymentowo-cenowych stanowiących Załącznik nr 1a do SWZ. Pakiet 1 - Crizotinib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 2 - Afatinib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 3 - Azacitidine. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 4 - Zanubrutynib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 5 - Lorlatinib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 6 - Regorafenib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 7 - Ripretinib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 8 - Blinatumomab. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 9 - Adagrasib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 10 - Ivosidenib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 11 - Ponatinib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 12 - Bosutinib. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 13 - Acidum zoledronicum. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 14 - Gemtuzumab. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 15 - Midostaurin. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.; Pakiet 16 - Immunoglobulina. Szczegółowe wymagania dotyczące asortymentu znajdują się pod Formularzem asortymentowo-cenowym stanowiącym Załącznik nr 1a do SWZ.

16 lots

Lot 1
Pakiet 1 – Crizotinib 12 months
Lot 2
Pakiet 2 – Afatinib 12 months
Lot 3
Pakiet 3 – Azacitidine 12 months
Lot 4
Pakiet 4 – Zanubrutynib 12 months
Lot 5
Pakiet 5 – Lorlatinib 12 months
Lot 6
Pakiet 6 – Regorafenib 12 months
Lot 7
Pakiet 7 – Ripretinib 12 months
Lot 8
Pakiet 8 – Blinatumomab 12 months
How tenders are scored
Cena ofertowa brutto: 100 points
Small firms
The buyer marks this procedure as suitable for small and medium-sized firms.
Show 8 more lots
Lot 9
Pakiet 9 – Adagrasib 12 months
Lot 10
Pakiet 10 – Ivosidenib 12 months
Lot 11
Pakiet 11 – Ponatinib 12 months
Lot 12
Pakiet 12 – Bosutinib 12 months
Lot 13
Pakiet 13 – Acidum zoledronicum 12 months
Lot 14
Pakiet 14 – Gemtuzumab 12 months
Lot 15
Pakiet 15 – Midostaurin 12 months
Lot 16
Pakiet 16 – Immunoglobulina. 12 months

As the official notice states them.

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    13 days left, 9 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    This buyer usually awards this kind of contract for between €244,800 and €4.7M.

  6. In your favour:

    Do we know this buyer?

    52 different companies won the last 53 comparable contracts.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in Polish.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 days ago

What this buyer has paid before

Based on 52 comparable contracts this buyer awarded in this sector over the last 4 years.

Median award
€842,017
Middle half of past awards
€244,800 to €4.7M

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach

Poland

notices in the register
248
awards
106
awarded in total
€457.6M

Who wins its contracts

Many suppliers
different companies won its awards
91
of the awards went to the three most frequent winners
6%
of its calls state an estimated value
0%

Based on 103 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
2.0
of those lots received a single tender
58%
of the awards went to companies based in another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Who usually wins this buyer's contracts in this sector

Based on 53 awards with a linked company profile over the last 5 years.

13 open tenders right now

Market context

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Medical equipment & pharmaceuticals
8,536
median open notice
€294,396

Who wins in this market

Many suppliers

Poland · Medical equipment & pharmaceuticals

different companies won awards here
13,478
of the awards went to the three most frequent winners
4%
buyers awarded contracts here
1,464

Based on 23,086 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.8
of those lots received a single tender
63%
of the awards went to companies based in another country
2%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

963 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.

13 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language